Hologic Inc (HOLX)

Profitability ratios

Return on sales

Sep 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Gross profit margin 55.28% 49.93% 50.92% 51.40% 51.65% 55.91% 58.87% 61.64% 63.35% 64.22% 65.56% 67.40% 68.86% 68.91% 65.57% 58.98% 46.89% 45.83% 34.56% 34.77%
Operating profit margin 21.90% 13.70% 15.22% 16.58% 16.76% 23.15% 28.24% 33.73% 37.10% 37.72% 40.71% 44.04% 47.22% 47.13% 41.13% 29.26% 11.70% 10.23% -4.12% -3.68%
Pretax margin 21.46% 14.15% 15.83% 16.78% 16.69% 22.44% 26.99% 32.66% 35.50% 36.06% 39.15% 41.92% 45.34% 45.10% 38.29% 26.52% 7.95% 6.25% -7.81% -7.66%
Net profit margin 19.59% 11.78% 12.98% 11.31% 11.99% 18.56% 22.17% 26.78% 28.93% 28.78% 31.23% 33.20% 35.93% 35.78% 30.38% 29.41% 14.98% 13.56% 2.47% -6.05%

Hologic Inc's profitability ratios have shown variability over the periods analyzed. The gross profit margin has fluctuated within a range, with a downward trend from 2019 to 2020, followed by an upward trend from 2020 to 2022, and then a gradual decrease up to 2024.

The operating profit margin has also displayed fluctuations, with a significant increase from 2020 to 2021, followed by a downward trend up to 2024. This indicates a mixed performance in converting revenue into operating profit, with periods of improvement and decline.

The pretax margin has shown a similar pattern to the operating profit margin, with fluctuations over the years. The trend indicates that Hologic Inc has experienced variations in its ability to generate profit before taxes, with periods of growth and contraction.

The net profit margin has also demonstrated variability, with fluctuations in profitability after accounting for all expenses and taxes. The trend reflects changes in the company's overall profitability, showing both periods of growth and decline.

In conclusion, Hologic Inc's profitability ratios suggest a mixed performance over the periods analyzed, with fluctuations in gross profit margin, operating profit margin, pretax margin, and net profit margin. The company's ability to maintain and improve profitability will be crucial for its long-term financial performance.


Return on investment

Sep 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Operating return on assets (Operating ROA) 9.64% 6.23% 7.13% 7.31% 7.25% 9.94% 13.58% 18.08% 20.72% 21.37% 24.08% 27.81% 31.12% 31.15% 24.71% 15.36% 5.67% 4.98% -2.21% -1.92%
Return on assets (ROA) 8.62% 5.35% 6.08% 4.99% 5.18% 7.97% 10.66% 14.35% 16.16% 16.31% 18.48% 20.96% 23.68% 23.65% 18.25% 15.43% 7.25% 6.61% 1.32% -3.16%
Return on total capital 12.94% 9.17% 10.27% 10.43% 9.80% 12.50% 16.49% 21.90% 24.95% 26.78% 30.55% 35.42% 40.78% 38.66% 31.03% 20.63% 7.79% 7.07% -2.53% -2.39%
Return on equity (ROE) 15.39% 9.63% 11.07% 9.09% 9.34% 14.21% 19.44% 26.70% 30.25% 32.38% 37.96% 44.32% 52.47% 50.14% 42.17% 41.05% 21.88% 21.62% 3.71% -9.62%

Hologic Inc's profitability ratios have shown variations over the past few quarters.

The operating return on assets (Operating ROA) has fluctuated but generally remained at a healthy level, ranging from around 5% to over 30% in the past two years. This indicates that the company has been efficient in generating operating income from its assets.

The return on assets (ROA) has also experienced fluctuations, ranging from negative values to over 23% in recent quarters. Despite some variability, the company has shown an ability to generate profits relative to its total assets.

Return on total capital has generally been positive and has displayed an upward trend from negative values to around 40% in recent quarters. This indicates that the company has been able to generate substantial returns relative to its total capital employed.

Return on equity (ROE) has also shown variations, fluctuating between 3% and over 50% in the past two years. This suggests that the company has been able to generate significant returns for its equity shareholders, although there have been fluctuations in profitability.

Overall, Hologic Inc has demonstrated the ability to generate profitability from its assets, capital, and equity, although there have been fluctuations in performance across different quarters. Further analysis and monitoring of these ratios are recommended to assess the company's long-term profitability prospects.